Information from law enforcement seizures that took place between 2022 and 2024 indicates that the availability and potential for diffusion within the Union of 2-MMC, NEP and 4-BMC has recently increased and may be significant. Information on the acute toxicity of 2-MMC, NEP and 4-BMC is limited. Nevertheless, the available data would suggest that the health risks of these three substances are comparable to those associated with the use of other synthetic cathinones under international control. Due to lack of studies, there is uncertainty on the dependence potential and abuse liability of 2-MMC, NEP and 4-BMC. This harm to health is considered life-threatening because it may cause death or lethal injury, severe disease, severe physical or mental impairment or a spread of diseases, including the transmission of blood-borne viruses, such as hepatitis C and HIV. These effects are comparable with other closely related synthetic cathinones and psychostimulants under international control, although this requires further study.
Recital 18, Directive (EU) 2025/2062
In forcesince 14 Oct 2025